COAGULATION FACTOR VIII INHIBITOR SCREEN PLASMA
Marquette General Health System

General Info

HLAB/HOL Code

  FAC8I

MGH LIS Test No

  192

Schedule

  Monday-Friday

Testing Time

   

Testing Lab

  Mayo Labs

QORR Test Code

  FAC8I

Specimen Info

Type

     

Volume

   

Temperature

  Frozen

Preservative

   

Collection Info

  1. Draw blood in a light blue-top (citrate) tube(s). Spin down, remove 
     plasma, spin plasma again, and place 3 mL of platelet-poor 
     plasma into 3 plastic vials each containing 1 mL. (Glass 
    vial is not acceptable.)
    Note: 1. Specimen must be drawn prior to factor 
                      replacement therapy.
                  2. Double-centrifuged specimens are critical for
                      accurate results as platelet contamination may
                      cause spurious results.
2. Freeze specimens immediately at < or = -40 degrees C, if possible.
3. Send specimens frozen in the same shipping container.
    Note: Each coagulation assay requested should have its own
                  vial.
4. If priority specimen, mark requisition, give reason, and request a 
     call-back.

 
Specimen Acceptability

Methods

Clinical Utilities

CPT Codes
85240/Factor VIII activity assay 85335/Factor VIII inhibitor (if appropriate) 85335/Bethesda Units (if appropriate) 80500/Interpretation (if interpretation provided by consultant)

Reference Range
FACTOR VIII ACTIVITY ASSAY
      55-205%
      Normal, full-term newborn infants or healthy premature infants 
      usually have normal or elevated factor VIII.*
       
FACTOR VIII INHIBITOR SCREEN
      Negative
      If positive, quantitated in Bethesda units.

BETHESDA TITER
      0 Units

Component Information

Collection Notes

Additional Comments

 

Questions or Comments email support@mgh.org

Reference Lab Home Page
Laboratory Main Page
Marquette General Health System Home Page